Article info

Download PDFPDF

Protocol
Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial)

Authors

  1. Correspondence to Dr Akira Mitsuhashi; antira{at}faculty.chiba-u.jp
View Full Text

Citation

Mitsuhashi A, Kawasaki Y, Hori M, et al
Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial)

Publication history

  • Received October 30, 2019
  • Revised January 18, 2020
  • Accepted February 10, 2020
  • First published February 28, 2020.
Online issue publication 
February 28, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.